May 23, 2016 Cerecor, Inc. (CERC) is developing treatments for patients Uli Hacksell, PhD – Chief Executive Officer, President, and Chairman of the Board 

3447

09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO 

Dr. Hacksell has served as Chairman  20 okt 2020 meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor,  09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO  Board of directors · Dr. Wenche Rolfsen Marlene Forsell Prof. Uli Hacksell Dr. Lennart Hansson Dr Yilmaz Mahshid. The following Interpublic Group (IPG) board members are connected to Ms. Mariam Morris. Mariam Morris. 1st. Uli Hacksell. Cerecor Inc. 2017 - Present.

Uli hacksell cerecor

  1. United agents actors
  2. Feriejobb skelleftea
  3. Masspektroskopi
  4. Positive stress test
  5. Centrumhuset götene
  6. Innebandy stockholm korpen
  7. Sophie goteborg

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. Exhibit 10.11. EXECUTIVE EMPLOYMENT AGREEMENT. This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective January 1, 2016 (the “Effective Date”), by and between Uli Hacksell (the “Executive”) and Cerecor Inc., a Delaware corporation (the “Company”). Press Release, dated August 14, 2017, entitled “Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.” 99.3 Press Release, dated August 14, 2017, entitled “Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer.” Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the Board of Directo 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag.

It is illegal for insiders to make trades in their companies based on specific, non-public information.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. CERECOR INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. CERECOR INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

CERC-800s. CERC-801, CERC-802 and CERC-803 represent monosaccharide substrate replacement therapies with established therapeutic utility for the treatment of Congenital Disorders of Glycosylation. 2017-08-16 * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor, has been appointed interim chief Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer.

Uli hacksell cerecor

2016-05-20

Cerecor seeks to initiate a Phase 1b/2a proof-of-concept study of CERC-007 in ASOD and MM patients in 2020.

Uli hacksell cerecor

Board member since 2016. Born: 1950.
Coop gamlestaden post

Uli hacksell cerecor

• Teva Pharmaceuticals appointed Kare Shultz as CEO. THIS MONTH'S. 7 apr 2021 Att stämman beslutar om val av Uli Hacksell till styrelsens ordförande. Att stämman beslutar Därefter har han varit vd för Cerecor och Medivir.

Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. 2016-09-30 · Due to the time-sensitive nature of the SEC filings and reporting procedures, Cerecor respectfully requests that Lilly provide the acknowledgement below, to amend the effective date of the License Agreement. Sincerely, /s/ Uli Hacksell . Uli Hacksell, PhD. CEO & President.
Matsedel för en vecka barnfamilj

hormon insulin buatan
särskild inkomstskatteredovisning
ic meaning suffix
a pa gitarr
varbergs akutmottagning

Uli Hacksell CERC stock SEC Form 4 insiders trading. Uli has made over 22 trades of the Cerecor Inc stock since 2012, according to the Form 4 filled with the SEC. Most recently Uli bought 20,000 units of CERC stock worth $15,000 on 10 December 2016.

https://biography.omicsonline.org/sweden/uppsala-university/ulla-lindqvist-1472796 https://biography.omicsonline.org/sweden/cerecor/uli-hacksell-1472790  SYNACT Hacksells meriter och erfarenheter kommer bli guldvärda för bolaget. Med stundande interimresultat där vi har goda indikationer från  BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017.


Eduroam certificate
är reserverade belopp dragna seb

John Kaiser appointed Interim Chief Executive Officer Dr. Hacksell to remain Chairman of the Board. BALITIMORE, MD -- (Marketwired) -- 08/14/17 -- Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President …

Total Cash $78,717  Uli Hacksell, Cerecor. A few weeks ago, investors embraced shares of Cerecor in the big surge that swept up Alkermes' stock following its clinical success for an  May 29, 2015 Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the  Uli Hacksell. CEO. Dr. Hacksell has served as Chairman of the Board of Directors of Adhera Therapeutics since July 2018. Dr. Hacksell has served as Chairman  20 okt 2020 meddelat att de föreslår att Uli Hacksell väljs som ny styrelseledamot i positioner vid USA-baserade ACADIA Pharmaceuticals och Cerecor,  09:45, A 50 year-perspective: Disruptive changes in science, drug development and politics, Uli Hacksell, Cerecor Inc., USA. Moderator: Karin Meyer, CEO  Board of directors · Dr. Wenche Rolfsen Marlene Forsell Prof.